Please ensure Javascript is enabled for purposes of website accessibility

Cannabis component eyed as cancer drug

Nuvilex Inc., of Silver Spring, a clinical-stage international biotechnology company that uses proprietary technology to treat diseases such as cancer and diabetes, said it signed a research agreement with the University of Northern Colorado to perform initial studies in the development of cancer treatments that combine its proprietary live-cell encapsulation technology known as Cell-in-a-Box with components of cannabis known as cannabinoids.

The agreement provides a foundation for future preclinical studies and clinical trials that will be needed as medical marijuana science develops treatments for serious and deadly diseases such as brain and pancreatic cancers, according to Nuvilex officials.